Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index, and 1 are not checked yet.

Cycle Checkpoint Abnormalities during Dementia: A Plausible Association with the Loss of Protection against Oxidative Stress in Alzheimer’s Disease

Open access

Abstract

BACKGROUND: Increasing evidence suggests an association between neuronal cell cycle (CCL) events and the processes that underlie neurodegeneration in Alzheimer's disease (AD). Elevated levels of oxidative stress markers and mitochondrial dysfunction are also among early events in AD. Recent studies have reported the role of CCL checkpoint proteins and tumor suppressors, such as ATM and p53 in the control of glycolysis and oxidative metabolism in cancer, but their involvement in AD remains uncertain. METHODS AND FINDINGS: In this postmortem study, we measured gene expression levels of eight CCL checkpoint proteins in the superior temporal cortex (STC) of persons with varying severities of AD dementia and compare them to those of cognitively normal controls. To assess whether the CCL changes associated with cognitive impairment in AD are specific to dementia, gene expression of the same proteins was also measured in STC of persons with schizophrenia (SZ), which is also characterized by mitochondrial dysfunction. The expression of CCL-checkpoint and DNA damage response genes: MDM4, ATM and ATR was strongly upregulated and associated with progression of dementia (cognitive dementia rating, CDR), appearing as early as questionable or mild dementia (CDRs 0.5-1). In addition to gene expression changes, the downstream target of ATM-p53 signaling - TIGAR, a p53-inducible protein, the activation of which can regulate energy metabolism and protect against oxidative stress was progressively decreased as severity of dementia evolved, but it was unaffected in subjects with SZ. In contrast to AD, different CCL checkpoint proteins, which include p53, CHEK1 and BRCA1 were significantly downregulated in SZ. CONCLUSIONS: These results support the activation of an ATM signaling and DNA damage response network during the progression of AD dementia, while the progressive decrease in the levels of TIGAR suggests loss of protection initiated by ATM-p53 signaling against intensifying oxidative stress in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0068361

Cites

89 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The mitotic cell cycle checkpoint gene network generated by the MetaCore and overlaid with the color coded gene expression changes during dementia. (red – upregulation; blue – downregulation; combination red/blue – differential effect at various stages of dementia). Highlighted is ATM/ATR regulation of G1/S transition pathways. The tumor protein p53 is a hub gene in this network.
Figure 1 The mitotic cell cycle checkpoint gene network generated by the MetaCore and overlaid with the color coded gene expression changes during dementia. (red – upregulation; blue – downregulation; combination red/blue – differential effect at various stages of dementia). Highlighted is ATM/ATR regulation of G1/S transition pathways. The tumor protein p53 is a hub gene in this network.CC BY · PubMed Central
Figure 2 Gene expression changes for ATM/ATR signaling pathway in STG (BA22) during progression of dementia (as a function of CDR). MDM4, ATM and ATR gene expression levels were significantly different in questionable-mild (CDR 0.5-1, light gray bars) and severe (CDR 2-5, dark gray bars) dementia groups relative to control group (black bars). REVs- relative expression values; * -p<0.05; ** -p≤0.01.
Figure 2 Gene expression changes for ATM/ATR signaling pathway in STG (BA22) during progression of dementia (as a function of CDR). MDM4, ATM and ATR gene expression levels were significantly different in questionable-mild (CDR 0.5-1, light gray bars) and severe (CDR 2-5, dark gray bars) dementia groups relative to control group (black bars). REVs- relative expression values; * -p<0.05; ** -p≤0.01.CC BY · PubMed Central
Figure 3 Gene expression changes for ATM/ATR signaling pathway in STG (BA22) in schizophrenia (gray bars) compared to controls (black bars). REVs- relative expression values; NL- controls; SZ- schizophrenia; * - p<0.05; *** - p<0.001.
Figure 3 Gene expression changes for ATM/ATR signaling pathway in STG (BA22) in schizophrenia (gray bars) compared to controls (black bars). REVs- relative expression values; NL- controls; SZ- schizophrenia; * - p<0.05; *** - p<0.001.CC BY · PubMed Central
Figure 4 Western blot (A) and protein expression levels of TIGAR (B) in STG (BA22) in dementia (CDRs >0.5) and schizophrenia. TIGAR expression values were normalized to GAPDH. **-p≤0.01; ***-p≤0.001.
Figure 4 Western blot (A) and protein expression levels of TIGAR (B) in STG (BA22) in dementia (CDRs >0.5) and schizophrenia. TIGAR expression values were normalized to GAPDH. **-p≤0.01; ***-p≤0.001.CC BY · PubMed Central
Figure 5 TIGAR is abundant in large pyramidal neurons in deep cortical layers (V–VI) of STG from the human brain. (A–C) Immunostaining for TIGAR visualized by peroxidase substrate DAB (brown staining) and counterstained with hematoxylin to visualize nuclei (blue). (D) Single staining with TIGAR; insert -negative control (secondary antibody staining). Strong staining of TIGAR was prevalent in cytoplasm and sometimes shows nuclear or perinuclear localization in large neurons as indicated by arrows (D).
Figure 5 TIGAR is abundant in large pyramidal neurons in deep cortical layers (V–VI) of STG from the human brain. (A–C) Immunostaining for TIGAR visualized by peroxidase substrate DAB (brown staining) and counterstained with hematoxylin to visualize nuclei (blue). (D) Single staining with TIGAR; insert -negative control (secondary antibody staining). Strong staining of TIGAR was prevalent in cytoplasm and sometimes shows nuclear or perinuclear localization in large neurons as indicated by arrows (D).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 89 references

Cited by

See all 52

Metadata

Authors
Katsel, P., Tan, W., Fam, P., Purohit, D. P., & Haroutunian, V.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • James J. Peters VA Medical Center (US)
Corresponding author
Katsel, Pavel
Venue
PLoS ONE
Published
2013-07-05
Volume
8
Issue
7
Pages
e68361
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1972266320
Cited by
52
References
89
Citations by year
2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 7 · 2017: 4 · 2016: 4 · 2015: 8 · 2014: 7
FWCI
4.40
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Leir Foundation
  • National Institutes of Health (MH066392, AG05138, AG02219)
  • National Institute on Aging (P50 AG 05138, P01 AG 02219, P50AG005138, P01AG002219)
  • National Institute of Mental Health (P50MH066392, MH066392, R01MH064673, MH-064673)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
Alzheimer's disease, dementia, cell cycle checkpoint proteins, oxidative stress, ATM signaling, p53, DNA damage response, TIGAR, MDM4, ATR, Chk1, BRCA1, superior temporal cortex, mitochondrial dysfunction, schizophrenia, gene expression, neurodegeneration
MeSH terms
Alzheimer Disease, Autopsy, Dementia, DNA Damage, Humans, Phosphoric Monoester Hydrolases, Temporal Lobe, Oxidative Stress, Disease Progression, Intracellular Signaling Peptides and Proteins, Apoptosis Regulatory Proteins, Gene Regulatory Networks, Cell Cycle Checkpoints, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cycle Checkpoint Abnormalities during Dementia: A Plausible Association with the Loss of Protection against Oxidative Stress in Alzheimer’s Disease. https://app.cochat.ai/papers/10.1371/journal.pone.0068361
The paper
Katsel, P., Tan, W., Fam, P., Purohit, D. P., & Haroutunian, V. (2013). Cycle Checkpoint Abnormalities during Dementia: A Plausible Association with the Loss of Protection against Oxidative Stress in Alzheimer’s Disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0068361

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.